| pubmed-article:2804082 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2804082 | lifeskim:mentions | umls-concept:C0025202 | lld:lifeskim |
| pubmed-article:2804082 | lifeskim:mentions | umls-concept:C0056303 | lld:lifeskim |
| pubmed-article:2804082 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:2804082 | pubmed:dateCreated | 1989-11-29 | lld:pubmed |
| pubmed-article:2804082 | pubmed:abstractText | The phenomenon of an elevated copper concentration in melanoma tumors was examined. It was demonstrated that 50-60% of total tissue copper is associated with metallothionein. The amino acid composition, electronic absorption and fluorescence were identical to that of the many known vertebrate Cu-thioneins. The immunological identification of melanoma tissue metallothionein was successful. The elevated Cu-thionein concentration in melanoma tumor tissue is not yet understood. It appears to be a common concept that in most tumors transient changes of the copper status parallel the metallothionein levels. | lld:pubmed |
| pubmed-article:2804082 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2804082 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2804082 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2804082 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2804082 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2804082 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2804082 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2804082 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2804082 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2804082 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:2804082 | pubmed:issn | 0006-3002 | lld:pubmed |
| pubmed-article:2804082 | pubmed:author | pubmed-author:WeserUU | lld:pubmed |
| pubmed-article:2804082 | pubmed:author | pubmed-author:NagelWW | lld:pubmed |
| pubmed-article:2804082 | pubmed:author | pubmed-author:HartmannH JHJ | lld:pubmed |
| pubmed-article:2804082 | pubmed:author | pubmed-author:KrauterBB | lld:pubmed |
| pubmed-article:2804082 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2804082 | pubmed:day | 9 | lld:pubmed |
| pubmed-article:2804082 | pubmed:volume | 1013 | lld:pubmed |
| pubmed-article:2804082 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2804082 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2804082 | pubmed:pagination | 212-7 | lld:pubmed |
| pubmed-article:2804082 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2804082 | pubmed:meshHeading | pubmed-meshheading:2804082-... | lld:pubmed |
| pubmed-article:2804082 | pubmed:meshHeading | pubmed-meshheading:2804082-... | lld:pubmed |
| pubmed-article:2804082 | pubmed:meshHeading | pubmed-meshheading:2804082-... | lld:pubmed |
| pubmed-article:2804082 | pubmed:meshHeading | pubmed-meshheading:2804082-... | lld:pubmed |
| pubmed-article:2804082 | pubmed:meshHeading | pubmed-meshheading:2804082-... | lld:pubmed |
| pubmed-article:2804082 | pubmed:meshHeading | pubmed-meshheading:2804082-... | lld:pubmed |
| pubmed-article:2804082 | pubmed:meshHeading | pubmed-meshheading:2804082-... | lld:pubmed |
| pubmed-article:2804082 | pubmed:meshHeading | pubmed-meshheading:2804082-... | lld:pubmed |
| pubmed-article:2804082 | pubmed:meshHeading | pubmed-meshheading:2804082-... | lld:pubmed |
| pubmed-article:2804082 | pubmed:meshHeading | pubmed-meshheading:2804082-... | lld:pubmed |
| pubmed-article:2804082 | pubmed:meshHeading | pubmed-meshheading:2804082-... | lld:pubmed |
| pubmed-article:2804082 | pubmed:meshHeading | pubmed-meshheading:2804082-... | lld:pubmed |
| pubmed-article:2804082 | pubmed:meshHeading | pubmed-meshheading:2804082-... | lld:pubmed |
| pubmed-article:2804082 | pubmed:meshHeading | pubmed-meshheading:2804082-... | lld:pubmed |
| pubmed-article:2804082 | pubmed:meshHeading | pubmed-meshheading:2804082-... | lld:pubmed |
| pubmed-article:2804082 | pubmed:meshHeading | pubmed-meshheading:2804082-... | lld:pubmed |
| pubmed-article:2804082 | pubmed:year | 1989 | lld:pubmed |
| pubmed-article:2804082 | pubmed:articleTitle | Copper-thionein in melanoma. | lld:pubmed |
| pubmed-article:2804082 | pubmed:affiliation | Anorganische Biochemie, Physiologisch-Chemisches Institut der Universität Tübingen, F.R.G. | lld:pubmed |
| pubmed-article:2804082 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2804082 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2804082 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2804082 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2804082 | lld:pubmed |
